Extramedullary disease in multiple myeloma

R Bansal, S Rakshit, S Kumar - Blood cancer journal, 2021 - nature.com
When clonal plasma cells grow at anatomic sites distant from the bone marrow or grows
contiguous from osseous lesions that break through the cortical bone, it is referred to as …

[HTML][HTML] Toward Digital Periodontal Health: Recent Advances and Future Perspectives

F Soheili, N Delfan, N Masoudifar, S Ebrahimni… - Bioengineering, 2024 - mdpi.com
Periodontal diseases, ranging from gingivitis to periodontitis, are prevalent oral diseases
affecting over 50% of the global population. These diseases arise from infections and …

[HTML][HTML] Advances in the treatment of extramedullary disease in multiple myeloma

Y Li, Z Sun, X Qu - Translational Oncology, 2022 - Elsevier
Extramedullary disease (EMD) is characterized by plasma cells outside of bone marrow in
multiple myeloma (MM) patients, which results in an adverse prognosis. The cornerstone of …

Survival outcomes of newly diagnosed multiple myeloma at a tertiary care center in North India (IMAGe: 001A Study)

U Yanamandra, R Sharma, S Shankar, S Yadav… - JCO Global …, 2021 - ascopubs.org
PURPOSE The outcomes of patients with myeloma from developing countries are often
lacking because of poor record maintenance. Publications from such settings are also …

Clinical characteristics and prognosis of multiple myeloma with myelomatous pleural effusion: a retrospective single-center study

L Gao, J Xu, W Xie, B Wang, X Cen… - Technology in Cancer …, 2022 - journals.sagepub.com
Objectives: Myelomatous pleural effusion is a rare presentation of extramedullary disease in
multiple myeloma, which has been reported with dismal prognosis. We aimed to explore …

Identification of evolutionary mechanisms of myelomatous effusion by single-cell RNA sequencing

Z Sun, J Ji, Y Li, Y Cui, L Fan, J Li, X Qu - Blood Advances, 2023 - ashpublications.org
Myelomatous effusion (ME) is a rare manifestation of extramedullary multiple myeloma (MM)
with limited therapeutic options and poor outcomes. The molecular mechanisms underlying …

Utilizing 3D Models to Unravel the Dynamics of Myeloma Plasma Cells' Escape from the Bone Marrow Microenvironment

SW Verbruggen, CL Freeman, FE Freeman - Cancers, 2024 - mdpi.com
Simple Summary New treatments have made a big difference in helping people with
multiple myeloma (MM) live longer. In fact, survival rates have almost doubled compared …

Digital financial inclusion in emerging economies: evidence from Jordan

A Al Khub, M Saeudy, AM Gerged - Journal of Risk and Financial …, 2024 - mdpi.com
This study explores the role of digital financial inclusion in mitigating poverty and bolstering
economic growth, with a special focus on developing nations during the COVID-19 era …

[HTML][HTML] Liquid extramedullary disease in multiple myeloma strongly predicts a poor prognosis and is associated with bortezomib resistance gene upregulation

J Ji, R Guo, J Ma, Y Cui, Y Li, Z Sun, J Li, L Fan… - Clinica Chimica Acta, 2023 - Elsevier
Background-aim Patients with multiple myeloma (MM) relapse with extramedullary disease
(EMD) exhibits an aggressive disease course and poor prognostic features. Myelomatous …

Recurrent pleural effusion in myeloma

WH Woo, A Ithnin, MAAFM Raffali… - Oxford Medical Case …, 2022 - academic.oup.com
Plasma cell (PC) disorders make up a spectrum of diseases which include myeloma and
amyloidosis. Pleural effusion in myeloma is rare and may result from myelomatous …